Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AXIOM is a private U.S. consumer wellness company selling hemp-derived CBD products and related skin-care formulations through the cbdaxiom.com website. Its commercial portfolio includes hemp oils, topical creams, face serum, and face cream products marketed around full-spectrum hemp, CO2 extraction, and proprietary carrier-blend formulation concepts. The company appears to operate as a retail/direct-to-consumer brand rather than a drug-development biotech, with products positioned for wellness, topical relief, and skin-care use. Publicly available materials do not indicate a clinical-stage pharmaceutical pipeline, regulatory drug approvals, or major pharma partnerships. Overall, AXIOM is best characterized as an active hemp/CBD wellness brand with commercial products rather than a traditional biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AXIOM.